• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氧气是原代人脑胶质瘤细胞免疫原性的主要调节因子。

Oxygen is a master regulator of the immunogenicity of primary human glioma cells.

机构信息

Department of Pediatrics, Graduate Program in Neuroscience, Biostatistics and Bioinformatics, University of Minnesota, Masonic Cancer Center, Minneapolis, Minnesota, USA.

出版信息

Cancer Res. 2011 Nov 1;71(21):6583-9. doi: 10.1158/0008-5472.CAN-11-1166. Epub 2011 Sep 9.

DOI:10.1158/0008-5472.CAN-11-1166
PMID:21908554
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3360979/
Abstract

With recent approval of the first dendritic cell (DC) vaccine for patient use, many other DC vaccine approaches are now being tested in clinical trials. Many of these DC vaccines employ tumor cell lysates (TL) generated from cells cultured in atmospheric oxygen (∼20% O₂) that greatly exceeds levels found in tumors in situ. In this study, we tested the hypothesis that TLs generated from tumor cells cultured under physiologic oxygen (∼5% O₂) would be more effective as a source for DC antigens. Gene expression patterns in primary glioma cultures established at 5% O₂ more closely paralleled patient tumors in situ and known immunogenic antigens were more highly expressed. DCs treated with TLs generated from primary tumor cells maintained in 5% O₂ took up and presented antigens to CD8 T cells more efficiently. Moreover, CD8 T cells primed in this manner exhibited superior tumoricidal activity against target cells cultured in either atmospheric 20% O₂ or physiologic 5% O₂. Together, these results establish a simple method to greatly improve the effectiveness of DC vaccines in stimulating the production of tumoricidal T cells, with broad implications for many of the DC-based cancer vaccines being developed for clinical application.

摘要

随着首个树突状细胞 (DC) 疫苗获得患者使用的批准,许多其他的 DC 疫苗方法正在临床试验中进行测试。许多这些 DC 疫苗采用从在大气氧(约 20% O₂)中培养的细胞生成的肿瘤细胞裂解物(TL),这大大超过了原位肿瘤中发现的水平。在这项研究中,我们测试了这样一个假设,即在生理氧(约 5% O₂)下培养的肿瘤细胞生成的 TL 作为 DC 抗原的来源会更有效。在 5% O₂下建立的原代胶质瘤培养物中的基因表达模式更接近原位患者肿瘤,并且已知的免疫原性抗原表达更高。用来自在 5% O₂下培养的原代肿瘤细胞生成的 TL 处理的 DC 更有效地摄取和呈递抗原给 CD8 T 细胞。此外,以这种方式引发的 CD8 T 细胞对在大气 20% O₂或生理 5% O₂中培养的靶细胞表现出优越的杀瘤活性。这些结果共同建立了一种简单的方法,可以大大提高 DC 疫苗刺激产生杀瘤性 T 细胞的有效性,这对许多正在开发用于临床应用的基于 DC 的癌症疫苗具有广泛的意义。

相似文献

1
Oxygen is a master regulator of the immunogenicity of primary human glioma cells.氧气是原代人脑胶质瘤细胞免疫原性的主要调节因子。
Cancer Res. 2011 Nov 1;71(21):6583-9. doi: 10.1158/0008-5472.CAN-11-1166. Epub 2011 Sep 9.
2
Antigen-specific T-cell response from dendritic cell vaccination using cancer stem-like cell-associated antigens.树突状细胞疫苗接种诱导的针对肿瘤干细胞样细胞相关抗原的抗原特异性 T 细胞反应。
Stem Cells. 2009 Aug;27(8):1734-40. doi: 10.1002/stem.102.
3
EphA2 as a glioma-associated antigen: a novel target for glioma vaccines.EphA2作为一种胶质瘤相关抗原:胶质瘤疫苗的新靶点。
Neoplasia. 2005 Aug;7(8):717-22. doi: 10.1593/neo.05277.
4
Tumor cell lysate-pulsed human dendritic cells induce a T-cell response against pancreatic carcinoma cells: an in vitro model for the assessment of tumor vaccines.肿瘤细胞裂解物脉冲处理的人树突状细胞诱导针对胰腺癌细胞的T细胞反应:一种评估肿瘤疫苗的体外模型。
Cancer Res. 2001 Sep 1;61(17):6445-50.
5
Cytotoxic T cell responses against mesothelioma by apoptotic cell-pulsed dendritic cells.凋亡细胞脉冲树突状细胞引发的针对间皮瘤的细胞毒性T细胞反应。
Am J Respir Crit Care Med. 2004 Jun 15;169(12):1322-30. doi: 10.1164/rccm.200312-1683OC. Epub 2004 Apr 7.
6
Tumor cell lysates as immunogenic sources for cancer vaccine design.肿瘤细胞裂解物作为癌症疫苗设计的免疫原性来源。
Hum Vaccin Immunother. 2014;10(11):3261-9. doi: 10.4161/21645515.2014.982996.
7
Dendritic cell vaccines based on immunogenic cell death elicit danger signals and T cell-driven rejection of high-grade glioma.基于免疫原性细胞死亡的树突状细胞疫苗引发危险信号并驱动T细胞介导的高级别胶质瘤排斥反应。
Sci Transl Med. 2016 Mar 2;8(328):328ra27. doi: 10.1126/scitranslmed.aae0105.
8
Spheroid glioblastoma culture conditions as antigen source for dendritic cell-based immunotherapy: spheroid proteins are survival-relevant targets but can impair immunogenic interferon γ production.球形体神经胶质瘤培养条件作为树突状细胞免疫治疗的抗原来源:球形体蛋白是与生存相关的靶标,但可损害免疫原性 IFN-γ的产生。
Cytotherapy. 2019 Jun;21(6):643-658. doi: 10.1016/j.jcyt.2019.03.002. Epub 2019 Apr 8.
9
Survivin is a shared tumor-associated antigen expressed in a broad variety of malignancies and recognized by specific cytotoxic T cells.生存素是一种在多种恶性肿瘤中表达的共同肿瘤相关抗原,并被特异性细胞毒性T细胞识别。
Blood. 2003 Jul 15;102(2):571-6. doi: 10.1182/blood-2002-08-2554. Epub 2003 Feb 6.
10
Tumor antigen-specific T cells for immune monitoring of dendritic cell-treated glioblastoma patients.用于树突状细胞治疗的胶质母细胞瘤患者免疫监测的肿瘤抗原特异性T细胞。
Cytotherapy. 2016 Sep;18(9):1146-61. doi: 10.1016/j.jcyt.2016.05.014. Epub 2016 Jul 14.

引用本文的文献

1
The regulation of immune checkpoints by the hypoxic tumor microenvironment.缺氧肿瘤微环境对免疫检查点的调控
PeerJ. 2021 May 7;9:e11306. doi: 10.7717/peerj.11306. eCollection 2021.
2
Hypoxia-Driven Immune Escape in the Tumor Microenvironment.肿瘤微环境中的缺氧驱动免疫逃逸。
Cells. 2020 Apr 16;9(4):992. doi: 10.3390/cells9040992.
3
Hypoxia induces immunogenic cell death of cancer cells by enhancing the exposure of cell surface calreticulin in an endoplasmic reticulum stress-dependent manner.缺氧通过以内质网应激依赖的方式增强细胞表面钙网蛋白的暴露,诱导癌细胞发生免疫原性细胞死亡。
Oncol Lett. 2019 Dec;18(6):6269-6274. doi: 10.3892/ol.2019.10986. Epub 2019 Oct 14.
4
Treatment Combining CD200 Immune Checkpoint Inhibitor and Tumor-Lysate Vaccination after Surgery for Pet Dogs with High-Grade Glioma.高级别胶质瘤宠物犬术后联合CD200免疫检查点抑制剂与肿瘤裂解物疫苗接种的治疗
Cancers (Basel). 2019 Jan 24;11(2):137. doi: 10.3390/cancers11020137.
5
Intra-tumoral treatment with oxygen-ozone in glioblastoma: A systematic literature search and results of a case series.胶质母细胞瘤中氧-臭氧的瘤内治疗:系统文献检索及病例系列结果
Oncol Lett. 2018 Nov;16(5):5813-5822. doi: 10.3892/ol.2018.9397. Epub 2018 Sep 5.
6
Monomeric annexin A2 is an oxygen-regulated toll-like receptor 2 ligand and adjuvant.单体 annexin A2 是一种氧调节型 toll 样受体 2 配体和佐剂。
J Immunother Cancer. 2016 Feb 16;4:11. doi: 10.1186/s40425-016-0112-6. eCollection 2016.
7
Effects of oxygen on the antigenic landscape of prostate cancer cells.氧气对前列腺癌细胞抗原格局的影响。
BMC Res Notes. 2015 Nov 18;8:687. doi: 10.1186/s13104-015-1633-7.
8
Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.通过疫苗疗法诱导人类和犬类脑肿瘤产生治疗反应的成败:最新技术综述
Crit Rev Immunol. 2014;34(5):399-432. doi: 10.1615/critrevimmunol.2014011577.
9
Hypoxia-inducible factors in regulation of immune responses in tumour microenvironment.缺氧诱导因子在肿瘤微环境免疫反应调控中的作用
Immunology. 2014 Dec;143(4):512-9. doi: 10.1111/imm.12380.
10
Vaccination with dendritic cells loaded with allogeneic brain tumor cells for recurrent malignant brain tumors induces a CD4(+)IL17(+) response.用加载同种异体脑瘤细胞的树突状细胞对复发性恶性脑肿瘤进行免疫接种可诱导产生 CD4+IL17+应答。
J Immunother Cancer. 2014 Feb 18;2:4. doi: 10.1186/2051-1426-2-4. eCollection 2014.

本文引用的文献

1
Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulose in patients with recurrent malignant glioma.α 型 1 极化树突状细胞和赖氨酸及羧甲基纤维素稳定的聚肌苷酸-聚胞苷酸联合疫苗接种诱导新型胶质细胞瘤相关抗原肽的 CD8+ T 细胞应答和复发性恶性神经胶质瘤患者的临床活性。
J Clin Oncol. 2011 Jan 20;29(3):330-6. doi: 10.1200/JCO.2010.30.7744. Epub 2010 Dec 13.
2
Superior efficacy of tumor cell vaccines grown in physiologic oxygen.在生理氧环境中生长的肿瘤细胞疫苗具有更好的疗效。
Clin Cancer Res. 2010 Oct 1;16(19):4800-8. doi: 10.1158/1078-0432.CCR-10-1572. Epub 2010 Sep 21.
3
Sipuleucel-T immunotherapy for castration-resistant prostate cancer.西普利单抗免疫治疗去势抵抗性前列腺癌。
N Engl J Med. 2010 Jul 29;363(5):411-22. doi: 10.1056/NEJMoa1001294.
4
Cellular vaccine approaches.细胞疫苗方法。
Cancer J. 2010 Jul-Aug;16(4):304-10. doi: 10.1097/PPO.0b013e3181eb33d7.
5
Landmark approval for Dendreon's cancer vaccine.丹德瑞恩癌症疫苗获里程碑式批准。
Nat Biotechnol. 2010 Jun;28(6):531-2. doi: 10.1038/nbt0610-531.
6
Hypoxia-inducible factors regulate tumorigenic capacity of glioma stem cells.缺氧诱导因子调节胶质瘤干细胞的致瘤能力。
Cancer Cell. 2009 Jun 2;15(6):501-13. doi: 10.1016/j.ccr.2009.03.018.
7
Physiologic oxygen concentration enhances the stem-like properties of CD133+ human glioblastoma cells in vitro.生理氧浓度在体外增强CD133+人胶质母细胞瘤细胞的干细胞样特性。
Mol Cancer Res. 2009 Apr;7(4):489-97. doi: 10.1158/1541-7786.MCR-08-0360.
8
CD133 is a marker of bioenergetic stress in human glioma.CD133是人类胶质瘤中生物能量应激的标志物。
PLoS One. 2008;3(11):e3655. doi: 10.1371/journal.pone.0003655. Epub 2008 Nov 5.
9
Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties.人源和鼠源胶质瘤细胞系中CD133+细胞的持久性:具有癌症干细胞样特性的GL261胶质瘤细胞的详细表征
Stem Cells Dev. 2008 Feb;17(1):173-84. doi: 10.1089/scd.2007.0133.
10
Spontaneous immune responses against glioma-associated antigens in a long term survivor with malignant glioma.一名恶性胶质瘤长期存活者针对胶质瘤相关抗原的自发免疫反应
J Transl Med. 2007 Dec 19;5:68. doi: 10.1186/1479-5876-5-68.